Ligne de temps
Cheïma Boudjeniba
Etudiant(e) en thèse
10 juin 2021
publication
A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome.
Lire plus01 janv. 2021
publication
Network-based repurposing identifies anti-alarmins as drug candidates to control severe lung inflammation in COVID-19.
Lire plus11 mai 2015